149 related articles for article (PubMed ID: 36822369)
1. Antigenic mapping of enterovirus A71 from Taiwan and Southeast Asia.
Cheng D; Huang SW; Tsai YH; Lien YY; Wang JR
Antiviral Res; 2023 Apr; 212():105569. PubMed ID: 36822369
[TBL] [Abstract][Full Text] [Related]
2. Enterovirus A71 Containing Codon-Deoptimized VP1 and High-Fidelity Polymerase as Next-Generation Vaccine Candidate.
Tsai YH; Huang SW; Hsieh WS; Cheng CK; Chang CF; Wang YF; Wang JR
J Virol; 2019 Jul; 93(13):. PubMed ID: 30996087
[TBL] [Abstract][Full Text] [Related]
3. VP1 codon deoptimization and high-fidelity substitutions in 3D polymerase as potential vaccine strategies for eliciting immune responses against enterovirus A71.
Hsieh W-S; Chao C-H; Shen C-Y; Cheng D; Huang S-W; Wang Y-F; Chen C-C; Chen S-H; Hsu L-J; Wang J-R
J Virol; 2024 Jan; 98(1):e0155823. PubMed ID: 38174926
[TBL] [Abstract][Full Text] [Related]
4. Mapping Enterovirus A71 Antigenic Determinants from Viral Evolution.
Huang SW; Tai CH; Fonville JM; Lin CH; Wang SM; Liu CC; Su IJ; Smith DJ; Wang JR
J Virol; 2015 Nov; 89(22):11500-6. PubMed ID: 26339057
[TBL] [Abstract][Full Text] [Related]
5. Neutralization of African enterovirus A71 genogroups by antibodies to canonical genogroups.
Volle R; Luo L; Razafindratsimandresy R; Sadeuh-Mba SA; Gouandjika-Valisache I; Horwood P; Duong V; Buchy P; Joffret ML; Huang Z; Duizer E; Martin J; Chakrabarti LA; Dussart P; Jouvenet N; Delpeyroux F; Bessaud M
J Gen Virol; 2023 Nov; 104(11):. PubMed ID: 37909282
[TBL] [Abstract][Full Text] [Related]
6. Emergence of genotype C1 Enterovirus A71 and its link with antigenic variation of virus in Taiwan.
Huang KA; Huang PN; Huang YC; Yang SL; Tsao KC; Chiu CH; Shih SR; Lin TY
PLoS Pathog; 2020 Sep; 16(9):e1008857. PubMed ID: 32936838
[TBL] [Abstract][Full Text] [Related]
7. Effects and mechanism of Aβ
Zhong M; Wang H; Yan H; Wu S; Wang K; Yang L; Cui B; Wu M; Li Y
Virol J; 2022 Sep; 19(1):151. PubMed ID: 36127711
[TBL] [Abstract][Full Text] [Related]
8. Development of a full-length cDNA-derived enterovirus A71 vaccine candidate using reverse genetics technology.
Yang YT; Chow YH; Hsiao KN; Hu KC; Chiang JR; Wu SC; Chong P; Liu CC
Antiviral Res; 2016 Aug; 132():225-32. PubMed ID: 27387826
[TBL] [Abstract][Full Text] [Related]
9. Electrostatic interactions at the five-fold axis alter heparin-binding phenotype and drive enterovirus A71 virulence in mice.
Tee HK; Tan CW; Yogarajah T; Lee MHP; Chai HJ; Hanapi NA; Yusof SR; Ong KC; Lee VS; Sam IC; Chan YF
PLoS Pathog; 2019 Nov; 15(11):e1007863. PubMed ID: 31730673
[TBL] [Abstract][Full Text] [Related]
10. A Novel Attenuated Enterovirus A71 Mutant with VP1-V238A,K244R Exhibits Reduced Efficiency of Cell Entry/Exit and Augmented Binding Affinity to Sulfated Glycans.
Meng T; Wong SM; Chua KB
J Virol; 2021 Oct; 95(22):e0105521. PubMed ID: 34468173
[TBL] [Abstract][Full Text] [Related]
11. Enterovirus A71 VP1 Variation A289T Decreases the Central Nervous System Infectivity via Attenuation of Interactions between VP1 and Vimentin In Vitro and In Vivo.
Zhu H; Cao Y; Su W; Huang S; Lu W; Zhou Y; Gao J; Zhao W; Zhang B; Wu X
Viruses; 2019 May; 11(5):. PubMed ID: 31121933
[TBL] [Abstract][Full Text] [Related]
12. Genomic Epidemiology and Phylodynamic Analysis of Enterovirus A71 Reveal Its Transmission Dynamics in Asia.
Xiao J; Huang K; Lu H; Song Y; Han Z; Zhang M; Li J; Zhou X; Chen J; Yu Q; Yang M; Yan D; Ji T; Yang Q; Zhu S; Xu W; Zhang Y
Microbiol Spectr; 2022 Oct; 10(5):e0195822. PubMed ID: 36200890
[TBL] [Abstract][Full Text] [Related]
13. A Selective Bottleneck Shapes the Evolutionary Mutant Spectra of Enterovirus A71 during Viral Dissemination in Humans.
Huang SW; Huang YH; Tsai HP; Kuo PH; Wang SM; Liu CC; Wang JR
J Virol; 2017 Dec; 91(23):. PubMed ID: 28931688
[TBL] [Abstract][Full Text] [Related]
14. A Polysaccharide Purified From
Lin YL; Shih C; Cheng PY; Chin CL; Liou AT; Lee PY; Chiang BL
Front Immunol; 2020; 11():561758. PubMed ID: 33117346
[TBL] [Abstract][Full Text] [Related]
15. Rosmarinic acid exhibits broad anti-enterovirus A71 activity by inhibiting the interaction between the five-fold axis of capsid VP1 and cognate sulfated receptors.
Hsieh CF; Jheng JR; Lin GH; Chen YL; Ho JY; Liu CJ; Hsu KY; Chen YS; Chan YF; Yu HM; Hsieh PW; Chern JH; Horng JT
Emerg Microbes Infect; 2020 Dec; 9(1):1194-1205. PubMed ID: 32397909
[TBL] [Abstract][Full Text] [Related]
16. Immune responses against enterovirus A71 infection: Implications for vaccine success.
Aw-Yong KL; NikNadia NMN; Tan CW; Sam IC; Chan YF
Rev Med Virol; 2019 Sep; 29(5):e2073. PubMed ID: 31369184
[TBL] [Abstract][Full Text] [Related]
17. Antibody signatures in hospitalized hand, foot and mouth disease patients with acute enterovirus A71 infection.
You L; Chen J; Cheng Y; Li Y; Chen YQ; Ying T; Turtle L; Yu H
PLoS Pathog; 2023 Jun; 19(6):e1011420. PubMed ID: 37262073
[TBL] [Abstract][Full Text] [Related]
18. Human Enterovirus 71 Protein Displayed on the Surface of Saccharomyces cerevisiae as an Oral Vaccine.
Zhang C; Wang Y; Ma S; Li L; Chen L; Yan H; Peng T
Viral Immunol; 2016 Jun; 29(5):288-95. PubMed ID: 27259043
[TBL] [Abstract][Full Text] [Related]
19. Enterovirus A71 capsid protein VP1 increases blood-brain barrier permeability and virus receptor vimentin on the brain endothelial cells.
Wang W; Sun J; Wang N; Sun Z; Ma Q; Li J; Zhang M; Xu J
J Neurovirol; 2020 Feb; 26(1):84-94. PubMed ID: 31512144
[TBL] [Abstract][Full Text] [Related]
20. Characterization of three small molecule inhibitors of enterovirus 71 identified from screening of a library of natural products.
Li G; Gao Q; Yuan S; Wang L; Altmeyer R; Lan K; Yin F; Zou G
Antiviral Res; 2017 Jul; 143():85-96. PubMed ID: 28412182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
